Patented drug therapy for lung condition has been exclusively optioned to Theratome Bio
IMAGE: This is Michael Coleman, president and CEO of Theratome Bio. view more Credit: Theratome Bio INDIANAPOLIS — A patented Indiana University School of Medicine discovery that uses proteins, lipids and nucleic acids secreted by adult stem cells to treat Acute Respiratory Distress Syndrome, or ARDS, has been optioned to Theratome Bio, an Indianapolis-based life sciences…